Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Clinical Study Evaluating the Safety, Tolerability, and Efficacy of Multiple Intravenous Administration of TP03HN106 in Patients With Critical Limb Ischemia

NCT06482892 is registered in ClinicalTrials.gov with Talengen Institute of Life Sciences, Shenzhen, P.R. China. as lead sponsor.

NCT NCT06482892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06482892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Clinical Study Evaluating the Safety, Tolerability, and Efficacy of Multiple Intravenous Administration of TP03HN106 in Patients With Critical Limb Ischemia
Lead sponsor
Talengen Institute of Life Sciences, Shenzhen, P.R. China.
Phase
Phase 2
Overall status
Completed
Start date
July 18, 2024
Completion date
May 30, 2026
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia